Specifically, inhibitors with targets related to glycolysis including hexokinase 2 (HK2) and lactate dehydrogenase A (LDHA) are useful in selectively killing cancer cells (Galluzzi et al., 2013). The gene discussed is LDHA; the disease is cancer.